SIGN UPLog In
Helexva
Company

Last deal

$2.2M

Amount

Seed

Stage

01.03.2024

Date

1

all rounds

$2.2M

Total amount

General

About Company
Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.
Contacts